Bookmark and Share

Last Minute: "'Middle-Class Joe' rakes in millions - POLITICO - POLITICO" Mon, 18 Mar 2019 09:01:00 GMT    "Beto O'Rourke walks back his 'born' to run for president remark amid criticism - AOL" Mon, 18 Mar 2019 00:25:05 GMT    "Boeing 737 Max training and FAA certification of new jets under scrutiny after Ethiopian Airways Flight 302 crash - CBS News" Mon, 18 Mar 2019 11:23:00 GMT    "New Zealand rampage suspect fires lawyer, may turn trial into platform for racist views - USA TODAY" Mon, 18 Mar 2019 13:13:40 GMT    "Facebook, YouTube and Twitter had to go to extraordinary lengths to take down mosque shooting videos - CNBC" Mon, 18 Mar 2019 13:19:00 GMT    "Trump finds plenty to be outraged about -- aside from New Zealand - CNN" Mon, 18 Mar 2019 12:44:00 GMT   "Utrecht shootings: Hunt for gunman after attack on tram - BBC News" Mon, 18 Mar 2019 13:01:20 GMT    "Another big Brexit week begins. What's expected? - Al Jazeera English" Mon, 18 Mar 2019 08:25:00 GMT    "Rivals pounce as Beto O'Rourke stumbles out of the gate - Washington Examiner" Sun, 17 Mar 2019 22:10:00 GMT    "Watch: Officer dragged by ATV as 100 drivers illegally take over street - WLWT Cincinnati" Mon, 18 Mar 2019 10:28:00 GMT      For more news, click here.

Authentication
       
       
Remember me? 

Fall of
--0.85 (+0.98%) Pfizer - [Ticker: PFE]Chart Pfizer  News Pfizer  Download Historical Prices for Metastock Pfizer and Others  Technical Analysis Pfizer  
Last Trade45.14Last Trade Time2018-12-04 - 00:00:00
Variation--0.85 (+0.98%)Open46.23
High46.47Low45.11
Volume26,062,310Average Volume (3m)0
YieldBid / Ask35.33 x 5,700 - 35.34 x 8,100
Former Close45.9952 Week Range[0.00 - 0.00]
PER0.00%EPS0.00
Ex-Dividend DateDividend Payment
Market Capitalization0 1 Year Price-Target0.00
Note: The data may have some minutes of delay.
Watch more quotes

Intraday   5 days   1 month   3 months   6 months   1 year   2 years   5 years   10 years            Use this chart on your website!
Pfizer -  [Ticker: PFE] chart
Change to Pfizer Interactive Technical Analysis Chart

Last 10 Forum Topics about Pfizer:
No topics about Pfizer [PFE] have been found, but a search on the Forum for more topics related to Pfizer is advised.

 News about Pfizer [PFE]:   (ordered by relevance)
Ochsner and Pfizer Constructing 'Digital Superhighway' for Clinical Trials  HealthLeaders Media

The alliance employs FHIR to quickly transmit data from the EHR with the hope of enhancing access to experimental therapies for patients and clinicians.

Pfizer (PFE) Gains But Lags Market: What You Should Know  Yahoo Finance

Pfizer (PFE) closed at $41.96 in the latest trading session, marking a +0.55% move from the prior day.

ACC: BMS, Pfizer's Eliquis tops warfarin in high-risk Afib subgroup  FiercePharma

Pfizer and Bristol-Myers Squibb's next-gen anticoagulant Eliquis has been stealing warfarin market share for years, but that doesn't mean it's slowing down.

The Thing That Hid Pfizer Inc. (PFE)'s Strength  Financial Mercury

Shares of Pfizer Inc. (NYSE:PFE) recorded 1.43% gain during trading session on March 15th, 2019. The script traded as low as $40.86 and last traded at $41.78.

Pfizer Inc. (PFE) Management Presents at Cowen and Company 39th Annual Health Care Conference (Transcript)  Seeking Alpha

Pfizer Inc. (NYSE:PFE) Cowen and Company 39th Annual Health Care Conference Call March 12, 2019 9:20 AM ET Company Participants Andy Schmeltz ...

Pfizer: This Biotech Blue-Chip Offers Market-Beating Total Return Potential  Seeking Alpha

Pfizer is a Dividend Challenger that has raised its dividend each year since 2010 and was actually a Dividend Aristocrat before a dividend cut during the Great.

ACC Roundup: Less Aspirin to Prevent Heart Attacks, Bristol-Myers & Pfizer, Apple Watch and More  BioSpace

The American College of Cardiology (ACC) annual meeting was held this weekend in New Orleans. Here's a look at some of the top stories that came out of the ...

What's the play on Wynn? Plus the trades on Citigroup & Pfizer in #AskHalftime  CNBC

The "Halftime Report" traders answer viewer questions on Wynn Resorts, Citigroup, Shopify, Dollar General, & Pfizer.

Pfizer's (PFE) Kidney Cancer Drug Combo Gets EMA's Validation  Zacks.com

Pfizer's (PFE) application for Bavencio in combination with Inlyta for the treatment of advanced RCC gets validated by EMA.

FDA Warns Jubilant, Pfizer Subsidiary in India  Regulatory Focus

The US Food and Drug Administration (FDA) last week sent warning letters to Pfizer's subsidiary Hospira and Jubilant Life Sciences over good manufacturing ...

Pfizer Agrees to Settle in Oregon Probe Over False Advertising  Insurance Journal

Pfizer has agreed to shell out $975,000 after Oregon's Department of Justice found the pharmaceutical giant misled consumers with deceptive coupons. Oregon ...

Pfizer Settles with Oregon Over Drug Price Coupons  Policy & Medicine

On March 11, 2019, Oregon Attorney General Ellen F. Rosenblum announced a nearly-$1 million settlement ($975,000.00) with Pfizer for distributing misleading ...

Pfizer plant that is closing gets farewell warning letter from FDA  FiercePharma

Gone but not forgotten. Last year, Pfizer stopped manufacturing and recalled products from a Hospira sterile injectables plant in India that the FDA has ...

Stocks with eye-catching figures: Pfizer Inc. (PFE), Comcast Corporation (CMCSA)  FinBulletin

Over the past 9 days, Pfizer Inc. (NYSE: PFE) stock was observed to have a Historic Volatility of 21.42%. That figure, when expanded to look at the past 100 days ...

Pfizer takes its option in AnTolRx deal; Secura Bio scores access to $145M for cancer drug launches  Endpoints News

... ? Two-and-a-half years after Pfizer stepped up to seed the biotech startup AnTolRx, the pharma giant has stepped in to take their option on an immune ...

Pfizer & Lilly's Pain Candidate Succeeds in Back Pain Study  Zacks.com

Pfizer (PFE) and Eli Lilly (LLY) announce that the higher dose of their investigational pain candidate, tanezumab, significantly reduces chronic low back pain in a ...

Pfizer in-licenses diabetes candidate from AnTolRx  Seeking Alpha

Pfizer (PFE -0.1%) exercises its option under a June 2016 agreement to exclusively in-license the lead candidate in privately held AnTolRx's type 1 diabetes ...

Pfizer's Forgotten Cancer Pill Is About to Become Its Next Blockbuster  Motley Fool

A drug that disappointed in 2018 will get an unexpected dance at the big ball.

Pfizer unit Meridian under civil investigation by U.S. Attorney  Reuters

Pfizer Inc said on Thursday it received a request for documents as part of a U.S. investigation related to quality issues involving the manufacture of auto-injectors ...

Pfizer In NASH: Left Behind And The Desperate Refocus  Seeking Alpha

Pfizer is a proven pioneer of therapeutics for HIV infection, autoimmune, cardiovascular and gastrointestinal diseases, as well as hematological and oncological.

Steady Activities: Pfizer, Inc. (NYSE:PFE), Nike, Inc. (NYSE:NKE)  The Newburgh Press

Pfizer, Inc. (NYSE:PFE) Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for ...

Street Bullish As Pfizer's Growth Is Set To Reaccelerate Beyond 2019  Seeking Alpha

Lyrica sales are expected to erode significantly over the next two years as generics enter the market. Pfizer's pipeline has strengthened significantly over the.

Better Buy: Pfizer vs. Eli Lilly  Motley Fool

One of these is paying a more generous dividend, but is it right for your portfolio?

Pfizer prices $5B debt offering  Seeking Alpha

Pfizer (PFE) prices a debt offering consisting of five tranches of notes: $500M aggregate principal amount of 2.800% notes due 2022, $750M 2.950% notes due.

D135 PFE brings candidates before parents during forum  The Orland Park Prairie

Taxpayers in Orland School District 135 recently had another chance to ask Board of Education members present and potentially future about the financial woes ...

Pfizer-Lilly drug shown to help reduce back pain in late-stage trial  Reuters

(Reuters) - A non-opioid painkiller developed by Pfizer Inc and Eli Lilly and Co succeeded in reducing chronic low back pain when used in a stronger dose, ...

Pfizer Prices US$5bn Bond As Corporate Debt Deluge Continues  Seeking Alpha

New York-based pharma giant Pfizer sold US$5bn of new corporate bonds Monday in five parts, as the company contributes to a groundswell of issuance amid ...

Should Analyst help in decision? Pfizer Inc. (PFE)  Voice Of Analysts

Pfizer Inc. (PFE) moved 1.43% to 41.78 on Friday. Pfizer Inc. received interesting focus from Active Investors and it has been trading on front line as seeing to it ...

Pfizer unit Meridian under civil investigation  Seeking Alpha

Pfizer (PFE) has received a request for documents as part of a U.S. investigation related to quality issues involving the manufacture of EpiPen auto-inject.

Study links Pfizer's Celebrex to heart valve problems  Seeking Alpha

A big-data analysis conducted at Vanderbilt University showed a link between Pfizer's (PFE +0.8%) arthritis med Celebrex (celecoxib) and heart valve ...

Plotting to go toe-to-toe with heavyweight Pfizer, little Eidos plans quick score in PhIII ATTR-CM study  Endpoints News

So how does a small cap biotech go toe-to-toe with the likes of Pfizer, when the pharma giant is lining up for one of the most carefully watched FDA decisions in ...

Pfizer: Countries free-riding on US innovation  BBC News

The chief executive of Pfizer has said US President Donald Trump should use trade deals to fight price controls on medicines in other countries. Albert Bourla ...

The Case Against Pfizer Stock and the Rest of the Industry  Investorplace.com

A recent article in the investment media asked if Pfizer stock was a better buy than Eli Lilly stock. Here's why I wouldn't buy either.

Merck, Pfizer drug combo extends kidney cancer survival: study  Reuters

(Reuters) - A combination of Merck & Co's immunotherapy Keytruda and Pfizer Inc's Inlyta helped patients with advanced kidney cancer live longer than those ...

Pfizer partners with Oschner to streamline data  OutSourcing-Pharma.com

Pfizer teams up with Oschner to digitize and streamline clinical trial data to make studies more inclusive and comprehensive. Oschner Health System, Lousiana's ...

Ochsner digitizing clinical trials through Pfizer partnership  Greater Baton Rouge Business Report

Ochsner Health System announced it has struck a multi-year ?strategic alliance? with pharmaceutical giant Pfizer Inc. to improve access and connectivity to ...

Pfizer tweaks Xeljanz trial after embolism safety signal  BioPharma Dive

Pfizer is transitioning patients in a post-marketing study off a higher-dose regimen of Xeljanz, following an independent analysis that found pulmonary ...

What Pharma Investors Need to Know About Pfizer's Latest Disaster  Motley Fool

Xeljanz recently ran into a safety problem, but investors aren't sure if this will open doors for similar drugs in development, or slam them shut.

Bristol-Myers Squibb-Pfizer Alliance reports data from AUGUSTUS trial  Drug Development Technology

The Bristol-Myers Squibb-Pfizer Alliance has reported positive results from the Phase IV AUGUSTUS trial that evaluated Eliquis (apixaban) versus vitamin K ...

Gliknik receives $15M payment from Pfizer after reaching clinical milestone  Technical.ly

The University of Maryland BioPark company's candidate drug is being developed to treat a rare neurological disorder. Gliknik receives $15M payment from ...

Pfizer to inject $355 million into pension plans in 2019  Pensions & Investments

Pfizer Inc., New York, expects to contribute a total of $355 million to its global pension plans this year.

The Zacks Analyst Blog Highlights: Pfizer, Roche, Merck, Allergan and J&J  Nasdaq

For Immediate ReleaseChicago, IL -March 18, 2019 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity.

Ochsner Health System and Pfizer team up to rethink clinical trials  MedCity News

The aim of their collaboration is to improve the patient clinical trial experience and ease participation in clinical research for patients and healthcare ...

Merck KGaA, Pfizer Join BioXcel-Nektar Collaboration, Creating Triple Combination Therapy for Pancreatic Cancer  Genetic Engineering & Biotechnology News

Pfizer and Merck KGaA, Darmstadt, Germany, have joined BioXcel Therapeutics in its clinical collaboration with Nektar Therapeutics, creating an expanded ...

Pfizer executive Sally Susman to host 2020 presidential fundraiser for Democrat Kirsten Gillibrand  CNBC

Gillibrand is to attend the March 31 fundraiser at the home of Pfizer executive Sally Susman, according to people with direct knowledge of the matter. Tickets ...

Pfizer Inc (PFE) Charge 2.18% Higher For the Week  Augusta Review

Pfizer Inc (PFE) shares are showing positive signals short-term as the stock has finished higher by 2.18% for the week. In taking a look at recent.

Recent Analysts Moves of Stock: Pfizer Inc. (PFE)  Nasdaq Click

Pfizer Inc. (PFE) stock price ended its day with gain 1.43% and finalized at the price of $41.78, its 52 week- peak value and changed 21.74% from its 52 ...

Return on Equity & Quant Signal Update for Pfizer Inc. (NYSE:PFE), UnitedHealth Group Incorporated (NYSE:UNH)  Stock News Oracle

In reviewing some key ratios and quant data for Pfizer Inc. (NYSE:PFE), we note that the mother of all ratios (Return on Equity) stands at 0.175932 for the.

Pfizer, Merck, J&J well-positioned for M&A and Biogen and BioMarin are prime targets: report  FiercePharma

M&A will help the biopharma industry deal with significant new challenges, Morningstar said in a new report, including pressure from lawmakers and payers to ...

Polaris Wealth Advisers Cut Its Position in Pfizer (PFE) by $335,314; Kiltearn Partners Llp Holding in Mckesson (MCK) Raised as Valuation Declined  Port Courier

Polaris Wealth Advisers Llc decreased its stake in Pfizer Inc (PFE) by 49.23% based on its latest 2018Q4 regulatory filing with the SEC. Polaris Wealth Kiltearn ...

Sizing Up Pfizer Inc. (NYSE:PFE) as Cash Flow Moves -0.05803  WallStreet.org

Pfizer Inc. (NYSE:PFE) has seen year over year cash flow change of -0.05803. This is calculated as the one year percentage growth of the firm's cash flow from ...

Diabetic Neuropathy Market: Comprehensive Study Explores Huge Growth in Future: Pfizer, Janssen Pharma, Eli Lilly and Company, Teva Pharma, Cephalon - Press Release  Digital Journal

Diabetic Neuropathy Comprehensive Study by Type (Peripheral Neuropathy, Autonomic Neuropathy, Proximal Neuropathy, Focal Neuropathy), Application ...

Celgene's Revlimid tops Medicare spending, shares the price-hike title with Pfizer's Lyrica  FiercePharma

One cancer drug, two diabetes drugs and two next-generation blood thinners topped the Medicare Part D charts for 2017?all with sales of more than $2.5 billion ...

BRIEF-Pfizer Receives European Approval For Zirabev, A Biosimilar To Avastin  Reuters

Feb 19 (Reuters) - Pfizer Inc: * PFIZER RECEIVES EUROPEAN APPROVAL FOR ZIRABEV (BEVACIZUMAB), A BIOSIMILAR TO AVASTIN. * EC APPROVAL ...

Does Pfizer's Xeljanz share its CV safety questions with burgeoning JAK class?  FiercePharma

Pfizer's rheumatoid arthritis drug Xeljanz has run into safety issues with its higher dose. But whether the issues belong to Xeljanz alone?rather than to its ...

Health Care Sector Update for 03/18/2019: DERM, TORC, SLNO, JNJ, PFE, ABT, MRK, AMGN  Nasdaq

Top Health Care Stocks:JNJ: -0.07%PFE: -0.24%ABT: +0.36%MRK: FlatAMGN: -0.08%Health care majors were mixed in Monday's pre-bell trading.Stocks ...

Pneumococcal Vaccines- Global Market Significant Players Sanofi Pasteur, Astellas Pharma Inc, Merck & Co. Inc., Pfizer Inc.  Global Industry Journal

Report Title Global Pneumococcal Vaccines Market Report 2019 covers detailed competitive outlook and systematic framework of Pneumococcal Vaccines ...

Zenith Epigenetics Announces US FDA Clearance of Investigational New Drug Application for ZEN-3694 in TNBC Program  Associated Press

This *content* is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation.

Global Gaucher Disease Market Insight Report 2019 ? Sanofi, Shire, Actelion Pharma, Pfizer  Operanewsnow

The Global ?Gaucher Disease Market? research report demonstrates the fast developing conditions of the global Gaucher Disease market. The report reveals ...

FDA OKs Pfizer's Herceptin biosimilar  Seeking Alpha

The FDA approves Pfizer's (PFE) TRAZIMERA (trastuzumab-gyyp), a biosimilar to Roche's (RHHBY) Herceptin, for the treatment of human epidermal growth ...

High Dose of Pfizer's Xeljanz Raises Red Flag in a Post-Marketing Study  BioSpace

Pfizer's blockbuster rheumatoid arthritis drug Xeljanz, a JAK inhibitor, has been a strong performer for the company, bringing in $1.77 billion in revenue last year.

Biosimilar Pipeline Analysis Market Is Booming Worldwide | Pfizer Inc., Novartis AG, Biocon, F. Hoffmann-La Roche Ltd, Amgen Inc., Kyowa Pharmaceutical Industry Co. Ltd, Boehringer Ingelheim GmbH  openPR

Biosimilar market is under the initial phase of development, they are used for the treatment of various disorders such as autoimmune disease, cancer as per ...

Wealthtrust Fairport Position in Conocophillips (COP) Raised by $1.39 Million; As Pfizer (PFE) Market Valuation Declined, Palo Capital Decreased Position by $378,916  The FinHeadLines

Wealthtrust Fairport Llc increased its stake in Conocophillips (COP) by 6103.83% based on its latest 2018Q4 regulatory filing with the SEC. Wealthtrust Palo ...

Riverhead Capital Management LLC Boosts Stake in Pfizer Inc. (PFE)  Fairfield Current

Riverhead Capital Management LLC raised its position in shares of Pfizer Inc. (NYSE:PFE) by 8.4% in the third quarter, according to its most recent 13F filing ...

Pfizer (PFE) Shareholder Caledonia Investments Plc Lowered Its Position by $2.58 Million; Geode Capital Management Has Increased Domtar (UFS) Holding by $1.72 Million  The FinReviewer

Caledonia Investments Plc decreased its stake in Pfizer Inc (PFE) by 14.15% based on its latest 2018Q4 regulatory filing with the SEC. Caledonia Investments ...

Fox News' Chris Wallace corners Kirsten Gillibrand on Pfizer fundraiser  Washington Examiner

Fox News anchor Chris Wallace grilled Democratic presidential candidate Sen. Kirsten Gillibrand of New York on Monday over holding fundraising events with ...

FDA cites an 'ongoing review' for Pfizer's blockbuster Xeljanz, with implications for the class  Endpoints News

On Wednesday a Pfizer representative told Endpoints News that the pharma giant had no immediate plans to take any new actions related to the marketing of ...

Sorrento Therapeutics, Inc. (SRNE) At $2.33 Forms Bottom; Gladius Capital Management LP Increased Its Pfizer (PFE) Stake  The FinReviewer

Sorrento Therapeutics, Inc. (SRNE) formed multiple bottom with $2.24 target or 4.00% below today's $2.33 share price. Sorrento Therapeutics, Inc. (SRNE) has ...

As Pfizer (PFE) Share Value Declined, Knott David M Decreased Position by $3.71 Million; Ny Comm Banc (NYCB) Stock Value Rose While Cutler Capital Management Has Decreased Its Stake by $386,100  Port Courier

Knott David M decreased its stake in Pfizer Inc. (PFE) by 19.17% based on its latest 2018Q4 regulatory filing with the SEC. Knott David M sold 86298 shares as ...

Pfizer drops 10 mg dose of best-selling Xeljanz as study spotlights cardio safety issue, higher rate of deaths  Endpoints News

One of Pfizer's top up-and-coming revenue producers has run into a serious safety issue during a post-marketing study. In order to read this article, you must ...

Pfizer, Ochsner Health team up for clinical trial innovation  MobiHealthNews

The pharma company and health system are looking to create digital tools to help make clinical trials easier for patients, clinicians and researchers.

What Does the Value Composite Score Say About Pfizer Inc. (NYSE:PFE)?  Martin Business Telegraph

Pfizer Inc. (NYSE:PFE) currently has a Value Composite score of 50. The Value Composite One (VC1) is a method that investors use to determine a.

Does Pfizer Inc. (NYSE:PFE) or The Walt Disney Company (NYSE:DIS) Have Solid Quant Signals?  Vassar News

Investors having Pfizer Inc. (NYSE:PFE) on their watchlists might want to take a look into the Gross Margin Score of the company. Pfizer Inc. currently has.

Protalix BioTherapeutics, Inc. filed on Mon, March 18 10-Q/A Form | Thorold News  Thorold News

Protalix BioTherapeutics, Inc. revealed 10-Q/A form on Mon, Mar 18.Since its approval by the FDA, taliglucerase alfa has been marketed by Pfizer Inc.

Pfizer Inc. (NYSE:PFE) Valuation in the Spotlight  Hartsburg News

Pfizer Inc. (NYSE:PFE) has an ERP5 rank of 4781. The ERP5 Rank is an investment tool that analysts use to discover undervalued companies. The ERP5 looks ...

Analysis: CEOs From Pfizer, Merck, AbbVie and Others Face Senate on Drug Prices  The Wall Street Journal

Rising drug prices were in focus as pharmaceutical industry executives testified before the Senate Finance Committee, with lawmakers taking issue with how ...

Liposomal Doxorubicin Market Development and Forecast Report 2019| Johnson & Johnson, Pfizer, Sun Pharmaceutical  openPR

The research study presented here is a highly detailed and meticulous account of almost all key aspects of the global Liposomal Doxorubicin market.

After Hours Most Active for Mar 13, 2019 : MSFT, LLY, F, CMCSA, PFE, FOX, CTL, HPQ, PCG, AMD, AAPL, ENDP  Nasdaq

The NASDAQ 100 After Hours Indicator is up 5.55 to 7262.53. The total After hours volume is currently 68599612 shares traded. The following.

2019 Clinical Trials Global Market ? IQVIA, Parexel, Covance, Pfizer, Paidion Research Inc.  Global Industry Journal

Report Title Global Clinical Trials Market Report 2019 covers detailed competitive outlook and systematic framework of Clinical Trials market at a global uniform ...

Teva launches generic Flector Patch in U.S.  Seeking Alpha

Teva Pharmaceutical Industries (TEVA) announces the U.S. commercial launch of its generic version of Pfizer's (PFE) Flector Patch (diclofenac epolamine top.

Pfizer, SIPTU attend WRC talks in dispute over pensions  RTE.ie

Representatives of the Pfizer multinational pharmaceutical company and SIPTU have attended negotiations at the Workplace Relations Commission in a bid to ...

Hospital Acquired Infections (HAI) Global Market 2019 : Cantel Medical Corp., Belimed AG, Abbott Laboratories, Pfizer Inc.  Global Industry Journal

Report Title Global Hospital Acquired Infections (HAI) Market Report 2019 covers detailed competitive outlook and systematic framework of Hospital Acquired ...

Pfizer spinout woos Otsuka vet Raymond Sanchez to lead CNS pipeline work; Joe Anderson returns to Arix helm  Endpoints News

... ? Four months after plopping itself down in the center of the neurosciences field with a pipeline from Pfizer and $350 million in launch cash from Bain Capital, ...

Analysts Call Attention:: Pfizer Inc., (NYSE: PFE)  Nyse Nasdaq News

Notable Technical and Performance analysis of the Pfizer Inc. stocks which belongs to US stocks Exchanges: On 15-03-2019 (Friday), Pfizer Inc., (NYSE: PFE) ...

Global Pain Management Drugs Market 2019 Merck, Endo International, AstraZeneca, Johnson & Johnson, Pfizer  Industry News Daily

The ?Global Pain Management Drugs Market 2018 Research Report? is an extensive Pain Management Drugs Market research report contains an introduction ...

Global Anemia Treatment Market 2019: Technology Innovation, Industry Demand, Growth Opportunities 2019-2025 | Pfizer, Johnson & Johnson, Roche, Novartis  The Market Fact

Global Anemia Treatment market insights relating to crucial aspects of the industry influencing its growth during the forecast period to 2025. It shows the sales of ...

Pfizer stokes rumor mill with plan to raise $5B in debt; Lilly's CGRP Emgality wins speedy review for cluster headaches  Endpoints News

Pfizer $PFE is raising $5 billion in debt, and in this heated M&A environment, there's quite a bit of buzz about what the money will be spent on. For the record ...

PFIZER LTD. (PFIZER.BO) Stock Drops Value Healthcare% For the Week  Bedford Journal

Shares of PFIZER LTD. (PFIZER.BO) have been trending lower over the past five bars, revealing bearish momentum for the shares, as they ran Healthcare% for ...

Global Chronic Idiopathic Constipation Drugs Market Forecast (2019-2024): Dominant Players Pfizer, Glaxosmithkline, Roche Holding AG  Global Industry Journal

Global Chronic Idiopathic Constipation Drugs Market Report thoroughly portrays an analysis of the growth direction grounded in the historic, current, and ...

Pfizer's biosimilar Zirabev wins EU approval  PharmaTimes

Pfizer has announced European approval of its Avastin biosimilar Zirabev. - News - PharmaTimes.

Global Bacterial Vaginosis Drug Market 2019 ? Bayer,Pfizer, Sanofi  Camping Canuck

A new market study on the global Bacterial Vaginosis Drug market has been recently added to the repository of eonmarketresearch.com. The research study ...

FDA Alerts on Increased Risks Linked to Pfizer's Xeljanz  Regulatory Focus

The US Food and Drug Administration (FDA) alerted the public late Monday of a post-marketing safety clinical trial for Xeljanz (tofacitinib) that found an ...

Global Atorvastatin Calcium Market Insight Report 2019 ? Pfizer, DSM Sinochem Pharmaceuticals, Cadila Pharmaceuticals  Operanewsnow

The Global ?Atorvastatin Calcium Market? research report demonstrates the fast developing conditions of the global Atorvastatin Calcium market. The report ...

Global Calcium Tablets Market Regional Analysis with Trending Manufactures are Pfizer ,A&Z Pharmaceutical ,Zhendong Group ,HPGC ,By-health  The B Gazette

The Global Calcium Tablets Market report provides Insightfull basic overview of the market. The analysis highlights opportunity and Calcium Tablets industry ...

Sleep Aid Supplements Market to Set Astonishing Growth by 2025 | Pfizer (Pharmacia & Upjohn), Sanofi Aventis, Sumitomo Dainippon Pharma (Sunovion) & more.  Microfinance Observer

Global Sleep Aid Supplements Market report covers the current scenario (with the base year being 2018) and the growth prospects of the global market for ...

Pfizer's blockbuster safety issue jumps the Atlantic as EMA launches its own review of Xeljanz  Endpoints News

After the FDA announced earlier this week that it is investigating the increased risk of blood clots and death linked to their blockbuster JAK inhibitor seen in a ...

Cancer Biomarker- Global Market Forecast Up to 2024 Significant Players Sanofi, Pfizer, Merck, AbbVie  Global Industry Journal

Report Title Global Cancer Biomarker Market Report 2019 covers detailed competitive outlook and systematic framework of Cancer Biomarker market at a global ...

(2019-2025) Global Anticoagulant Reversal Drugs Market Survey Report for Top Market Research Competitors ? Pfizer, Bausch Health Companies, Fresenius  The Market Fact

Global Anticoagulant Reversal Drugs Market research report interpret definition, an investigation of significant progress in the market. It presents the industry ...

Pfizer's earnings outlook disappoints after Viagra loses patent protection and Lyrica faces same fate  CNBC

Pharmaceutical giant Pfizer braced investors for little-to-no revenue growth in 2019 after its blockbuster erectile dysfunction drug Viagra and others lost patent ...

Mouth Ulcer Treatment Market Analysis by Pfizer, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, ECR Pharmaceuticals  openPR

Regional segmentation of the global mouth ulcers treatment market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America, ...

For more news about Pfizer click here:
Pfizer News
Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2019 - TR4DER.com, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources